Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$0.29.

  • PAVmed's EPS (Weighted Average and Diluted) changed N/A to -$0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.98, marking a year-over-year change of. This contributed to the annual value of $0.5 for FY2024, which is 10541.4% up from last year.
  • PAVmed's EPS (Weighted Average and Diluted) amounted to -$0.29 in Q3 2025.
  • Over the past 5 years, PAVmed's EPS (Weighted Average and Diluted) peaked at $0.34 during Q1 2025, and registered a low of -$14.25 during Q4 2022.
  • For the 4-year period, PAVmed's EPS (Weighted Average and Diluted) averaged around -$2.22, with its median value being -$1.19 (2024).
  • Per our database at Business Quant, PAVmed's EPS (Weighted Average and Diluted) plummeted by 72068.97% in 2023 and then skyrocketed by 11297.71% in 2025.
  • Quarter analysis of 4 years shows PAVmed's EPS (Weighted Average and Diluted) stood at -$14.25 in 2022, then soared by 84.57% to -$2.2 in 2023, then soared by 98.88% to -$0.02 in 2024, then crashed by 1080.46% to -$0.29 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.29 in Q3 2025, compared to -$0.74 in Q2 2025 and $0.34 in Q1 2025.